The Community Oncology Alliance (COA) annual meeting was held April 4-5 in Orlando, FL. This year's focus was on ensuring quality, affordable, and accessible cancer care.
Journal of Clinical Pathways was onsite to provide coverage of the most relevant and important sessions of the meeting.
Lee Schwartzberg, MD, FACP, covers a range of topics, including a session he led at the COA Annual Meeting involving the “misguided” practice of step therapy, clinical pathways as a conduit for decreased resource utilization, and his involvement with OneOncology.
Tracy L Bahl, Jeff Vacirca, MD, FACP, and Robin Shah—three of the leaders of OneOncology, a new partnership of independent community oncology practices—provide the details of what makes OneOncology different than other leading community practice collaborations as well as how it is built to withstand hospital consolidation.
Ray Page, DO, PhD, discusses an artificial intelligence pilot study, conducted at The Center for Cancer and Blood Disorders, to make a positive impact on patient care and decrease inefficiencies in care administration.
The opening session at the COA annual meeting featured a detailed conversation about artificial intelligence use in community oncology practices along with some of the perceptions and challenges of physician buy-in.
A session at the COA annual meeting stressed the importance of oncology clinical trials in the community setting and the efforts going on behind the scenes.